GEN article features Marchant, conference panelists
<p>An article in the June 15 issue of <em>Genetic Engineering & Biotechnology News</em>, “Pharmacogenomics on Its Way Toward Clinic,” is rooted in a conference co-hosted in March by the College of Law’s Center for Law, Science & Innovation.</p><separator></separator><p>Reporter Catherine Shaffer interviewed <a href="http://apps.law.asu.edu/Apps/Faculty/Faculty.aspx?individual_id=6">Gary Marchant</a>, the Center’s Executive Director and a planning committee member for the March 8-9 conference, “Personalized Medicine in the Clinic: Policy, Legal, and Ethical Implications,’ about moving pharmacogenomics from theory to practice.</p><separator></separator><p>Legal liability is an emerging issue with no easy answers, Marchant told Shaffer. “Very few doctors have training in genetics to handle those issues; most of them don’t look at the primary literature, and it’s all subject to retrospective analysis in the courtroom,” he said.</p><separator></separator><p>Shaffer also spoke with several conference participants, renowned leaders and scientists at the cutting edge of clinical patient care, cancer research and pathology, among others.</p><separator></separator><p>To read the full article, click <a href="http://www.genengnews.com/keywordsandtools/print/1/19553/">here</a>.<br /><br /><br /><span style="font-family: Tahoma; color: black; font-size: 9pt;" lang="EN">Janie Magruder, </span><a href="mailto:Jane.Magruder@asu.edu">Jane.Magruder@asu.edu</a><span style="font-family: Tahoma; color: black; font-size: 9pt;" lang="EN"><br />(480) 727-9052<br />Sandra Day O’Connor College of Law</span></p>